A

Aptamer Group PLC
LSE:APTA

Watchlist Manager
Aptamer Group PLC
LSE:APTA
Watchlist
Price: 0.9055 GBX -4.68%
Market Cap: 24.4m GBP

Net Margin

-2%
Current
Improving
by 1.7%
vs 3-y average of -3.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2%
=
Net Income
£-2.4m
/
Revenue
£1.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2%
=
Net Income
GBX-2.4m
/
Revenue
£1.2m

Peer Comparison

Country Company Market Cap Net
Margin
UK
Aptamer Group PLC
LSE:APTA
25.6m GBP
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
AU
CSL Ltd
ASX:CSL
85.7B AUD
Loading...
NL
argenx SE
XBRU:ARGX
41.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
No Stocks Found

Market Distribution

Lower than 90% of companies in United Kingdom
Percentile
10th
Based on 3 670 companies
10th percentile
-2%
Low
-188 120% — 0%
Typical Range
0% — 0.1%
High
0.1% — 10 443.9%
Distribution Statistics
United Kingdom
Min -188 120%
30th Percentile 0%
Median 0%
70th Percentile 0.1%
Max 10 443.9%

Aptamer Group PLC
Glance View

Market Cap
24.4m GBX
Industry
Biotechnology

Aptamer Group Plc operates as a biotechnology company. The firm provides custom Optimer selection and development services. The firm provides transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. The firm has developed a proprietary platform technology that drives three distinct businesses: Aptamer solutions for custom Optimer development, Aptamer diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer therapeutics for the development of Optimer-based therapeutics. Optimer can act as agonists, antagonists or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.

APTA Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2%
=
Net Income
£-2.4m
/
Revenue
£1.2m
What is Aptamer Group PLC's current Net Margin?

The current Net Margin for Aptamer Group PLC is -2%, which is above its 3-year median of -3.7%.

How has Net Margin changed over time?

Over the last 2 years, Aptamer Group PLC’s Net Margin has increased from -4.5% to -2%. During this period, it reached a low of -6.8% on Dec 31, 2023 and a high of -1.9% on Dec 31, 2024.

Back to Top